Theralase has been manufacturing super pulsed laser technology for 17 years, distributing this technology in Canada, the United States and Internationally.
Technology and protocols based on solid clinical research by our team of clinical and scientific researchers and the feedback of thousands of health care clinics worldwide.
On-going, cutting-edge clinical research at Princess Margaret Hospital, University of Buffalo and Virginia Tech University.
Medical advisory board chaired by renowned orthopedic surgeon Dr. James Andrews and consisting of elite practitioners Dr. Jeff Dugas, Dr. Lyle Cain and Kevin Wilk .
Over 1,000,000 patients successfully treated, with 1000's of Theralase lasers sold to satisfied health care providers.
Theralase complies with Health Canada, FDA, CE, ISO-13485 and CSA-601 regulatory approvals to ensure efficacy, safety and quality in manufacture.